Citations (49)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Dario Cattaneo, Deborah JE Marriott & Cristina Gervasoni. (2023) Hematological toxicities associated with linezolid therapy in adults: key findings and clinical considerations. Expert Review of Clinical Pharmacology 16:3, pages 219-230.
Read now
Read now
L. Morata, C. De la Calle, J. M. Gómez-Cerquera, L. Manzanedo, G. Casals, M. Brunet, N. Cobos-Trigueros, J. A. Martínez, J. Mensa & A. Soriano. (2016) Risk factors associated with high linezolid trough plasma concentrations. Expert Opinion on Pharmacotherapy 17:9, pages 1183-1187.
Read now
Read now
Dario Cattaneo, Jan-Willem Alffenaar & Michael Neely. (2016) Drug monitoring and individual dose optimization of antimicrobial drugs: oxazolidinones. Expert Opinion on Drug Metabolism & Toxicology 12:5, pages 533-544.
Read now
Read now
Yoichi Hiraki, Yasuhiro Tsuji, Nobuhiro Misumi, Mikako Hiraike, Kana Matsumoto, Kunihiko Morita, Hidetoshi Kamimura & Yoshiharu Karube. (2013) Pharmacokinetics and Elimination Efficiency of Linezolid during Dialysis. Renal Failure 35:3, pages 418-420.
Read now
Read now
Kazuaki Taguchi, Toshikazu Miyakawa, Takafumi Ohmura, Momoko Horio, Yoshihisa Anraku, Tatsuya Okada, Hiroshi Mizuta, Hideyuki Saito & Tatsuya Kawaguchi. (2013) A reduced linezolid dosage maintains favorable efficacy with minimal hematologic toxicity in a methicillin-resistant Staphylococcus aureus-infected patient with renal insufficiency. Scandinavian Journal of Infectious Diseases 45:1, pages 77-80.
Read now
Read now
Articles from other publishers (44)
Kazutaka Oda, Hideyuki Saito & Hirofumi Jono. (2023) Bayesian prediction-based individualized dosing of anti-methicillin-resistant Staphylococcus aureus treatment: Recent advancements and prospects in therapeutic drug monitoring. Pharmacology & Therapeutics 246, pages 108433.
Crossref
Crossref
Szu-Ting Huang, Jia-Ling Yang, Chi-Ying Lin, Sung-Hsi Huang, Jann-Tay Wang, Yu-Chung Chuang, Yee-Chun Chen & Shan-Chwen Chang. (2023) Risk factors for mortality after linezolid treatment of vancomycin-resistant Enterococcus bloodstream infection. International Journal of Infectious Diseases 129, pages 96-102.
Crossref
Crossref
Xiaoxi Liu, Mari Aoki, Sumika Osa, Chihiro Ito, Reika Saiki, Tomoya Nagai, Yuki Enoki, Kazuaki Taguchi & Kazuaki Matsumoto. (2022) Safety of linezolid in patients with decreased renal function and trough monitoring: a systematic review and meta-analysis. BMC Pharmacology and Toxicology 23:1.
Crossref
Crossref
Enrique Bandín-Vilar, Laura García-Quintanilla, Ana Castro-Balado, Irene Zarra-Ferro, Miguel González-Barcia, Manuel Campos-Toimil, Víctor Mangas-Sanjuan, Cristina Mondelo-García & Anxo Fernández-Ferreiro. (2022) A Review of Population Pharmacokinetic Analyses of Linezolid. Clinical Pharmacokinetics 61:6, pages 789-817.
Crossref
Crossref
Fan Wu, Xiao-Shan Zhang, Ying Dai, Zi-Ye Zhou, Chun-Hong Zhang, Lu Han, Fang-Min Xu, Ye-Xuan Wang, Da-Wei Shi, Guan-Yang Lin, Xu-Ben Yu & Fang Chen. (2022) Dosage Strategy of Linezolid According to the Trough Concentration Target and Renal Function in Chinese Critically Ill Patients. Frontiers in Pharmacology 13.
Crossref
Crossref
Can Chen, Yiwei Li, Jingdi Yu & Shenxian Qian. (2021) Linezolid-induced thrombocytopenia in patients with acute myeloid leukemia: a matched case–control study. Clinical and Translational Oncology 24:3, pages 540-545.
Crossref
Crossref
Mohd H. Abdul–AzizKara BradyMenino Osbert CottaJason A. Roberts. (2022) Therapeutic Drug Monitoring of Antibiotics: Defining the Therapeutic Range. Therapeutic Drug Monitoring 44:1, pages 19-31.
Crossref
Crossref
Jie Fang, Xiao-Shan Zhang, Chun-Hong Zhang, Zi-Ye Zhou, Lu Han, Ye-Xuan Wang, Xiao-Shuang He, Xiao-Lan Bian, Guan-Yang Lin, Zheng Jiao, Ying Dai, Xu-Ben Yu & Jing-Ye Pan. (2021) Model Based Identification of Linezolid Exposure–toxicity Thresholds in Hospitalized Patients. Frontiers in Pharmacology 12.
Crossref
Crossref
Ying Dai, Shuying Jiang, Xiaoou Chen, Lu Han, Chunhong Zhang, Xuben Yu & Xiuhua Zhang. (2021) Analysis of the risk factors of linezolid‐related haematological toxicity in Chinese patients. Journal of Clinical Pharmacy and Therapeutics 46:3, pages 807-813.
Crossref
Crossref
Saki Takahashi, Yasuhiro Tsuji, Hidefumi Kasai, Chika Ogami, Hitoshi Kawasuji, Yoshihiro Yamamoto & Hideto To. (2021) Classification Tree Analysis Based On Machine Learning for Predicting Linezolid-Induced Thrombocytopenia. Journal of Pharmaceutical Sciences 110:5, pages 2295-2300.
Crossref
Crossref
Chih-Ning Cheng, Chien-Chih Wu, Ching-Hua Kuo, Chi-Chuan Wang, Jann-Tay Wang, Ya-Ting Lin, Ren-Shiang Jhang & Shu-Wen Lin. (2021) Impact of high plasma concentrations of linezolid in Taiwanese adult patients— therapeutic drug monitoring in improving adverse drug reactions. Journal of the Formosan Medical Association 120:1, pages 466-475.
Crossref
Crossref
Ana Dioun Broyles, Aleena Banerji, Sara Barmettler, Catherine M. Biggs, Kimberly Blumenthal, Patrick J. Brennan, Rebecca G. Breslow, Knut Brockow, Kathleen M. Buchheit, Katherine N. Cahill, Josefina Cernadas, Anca Mirela Chiriac, Elena Crestani, Pascal Demoly, Pascale Dewachter, Meredith Dilley, Jocelyn R. Farmer, Dinah Foer, Ari J. Fried, Sarah L. Garon, Matthew P. Giannetti, David L. Hepner, David I. Hong, Joyce T. Hsu, Parul H. Kothari, Timothy Kyin, Timothy Lax, Min Jung Lee, Kathleen Lee-Sarwar, Anne Liu, Stephanie Logsdon, Margee Louisias, Andrew MacGinnitie, Michelle Maciag, Samantha Minnicozzi, Allison E. Norton, Iris M. Otani, Miguel Park, Sarita Patil, Elizabeth J. Phillips, Matthieu Picard, Craig D. Platt, Rima Rachid, Tito Rodriguez, Antonino Romano, Cosby A. StoneJr.Jr., Maria Jose Torres, Miriam Verdú, Alberta L. Wang, Paige Wickner, Anna R. Wolfson, Johnson T. Wong, Christina Yee, Joseph Zhou & Mariana Castells. (2020) Practical Guidance for the Evaluation and Management of Drug Hypersensitivity: Specific Drugs. The Journal of Allergy and Clinical Immunology: In Practice 8:9, pages S16-S116.
Crossref
Crossref
Gauri G. RaoRobyn KonickiDario CattaneoJan-Willem AlffenaarDeborah J. E. MarriottMichael Neely. (2020) Therapeutic Drug Monitoring Can Improve Linezolid Dosing Regimens in Current Clinical Practice: A Review of Linezolid Pharmacokinetics and Pharmacodynamics. Therapeutic Drug Monitoring 42:1, pages 83-92.
Crossref
Crossref
Abdullah Alsultan. (2019) Determining therapeutic trough ranges for linezolid. Saudi Pharmaceutical Journal 27:8, pages 1061-1063.
Crossref
Crossref
Chika Ogami, Yasuhiro Tsuji, Hideto To & Yoshihiro Yamamoto. (2019) Pharmacokinetics, toxicity and clinical efficacy of linezolid in Japanese pediatric patients. Journal of Infection and Chemotherapy 25:12, pages 979-986.
Crossref
Crossref
Ross Leader, James Hackett, Anne Allan & Paul Carter. (2018) Linezolid-induced pancytopenia. BMJ Case Reports, pages bcr-2018-225480.
Crossref
Crossref
Jana Stojanova & Sonia Luque. 2018. Antibiotic Pharmacokinetic/Pharmacodynamic Considerations in the Critically Ill. Antibiotic Pharmacokinetic/Pharmacodynamic Considerations in the Critically Ill
173
199
.
Takuya Yamashina, Moeko Tsuruyama, Miki Odawara, Minako Tsuruta, Hirochika Miyata, Aki Kozono, Yasuhiro Tsuji, Takanori Miyoshi, Yosei Kawamata & Yoichi Hiraki. (2017) Pharmacokinetics of linezolid during continuous hemodiafiltration: A case report. Journal of Infection and Chemotherapy 23:10, pages 709-712.
Crossref
Crossref
Sebastian G. Wicha, Otto R. Frey, Anka C. Roehr, Johann Pratschke, Martin Stockmann, Rawan Alraish, Tilo Wuensch & Magnus Kaffarnik. (2017) Linezolid in liver failure: exploring the value of the maximal liver function capacity (LiMAx) test in a pharmacokinetic pilot study. International Journal of Antimicrobial Agents 50:4, pages 557-563.
Crossref
Crossref
Yasuhiro Tsuji, Nicholas H.G. Holford, Hidefumi Kasai, Chika Ogami, Young-A Heo, Yoshitsugu Higashi, Akiko Mizoguchi, Hideto To & Yoshihiro Yamamoto. (2017) Population pharmacokinetics and pharmacodynamics of linezolid-induced thrombocytopenia in hospitalized patients. British Journal of Clinical Pharmacology 83:8, pages 1758-1772.
Crossref
Crossref
Dario Cattaneo, Cristina Gervasoni, Valeria Cozzi, Simone Castoldi, Sara Baldelli & Emilio Clementi. (2016) Therapeutic drug management of linezolid: a missed opportunity for clinicians?. International Journal of Antimicrobial Agents 48:6, pages 728-731.
Crossref
Crossref
Cecilia Martín-Gandul, M. J. Mayorga-Buiza, E. Castillo-Ojeda, M. J. Gómez-Gómez, M. Rivero-Garvía, M. V. Gil-Navarro, F. J. Márquez-Rivas & M. E. Jiménez-Mejías. (2016) Sequential antimicrobial treatment with linezolid for neurosurgical infections: efficacy, safety and cost study. Acta Neurochirurgica 158:10, pages 1837-1843.
Crossref
Crossref
Federico Pea, Piergiorgio Cojutti, Lucia Dose & Massimo Baraldo. (2016) A 1 year retrospective audit of quality indicators of clinical pharmacological advice for personalized linezolid dosing: one stone for two birds?. British Journal of Clinical Pharmacology 81:2, pages 341-348.
Crossref
Crossref
Hideo Kato, Yukihiro Hamada, Mao Hagihara, Jun Hirai, Yuka Yamagishi, Katsuhiko Matsuura & Hiroshige Mikamo. (2015) Bicytopenia, especially thrombocytopenia in hemodialysis and non-hemodialysis patients treated with linezolid therapy. Journal of Infection and Chemotherapy 21:10, pages 707-712.
Crossref
Crossref
Sara J. Jones, Kristen R. Nichols, Heather L. DeYoung, Elaine G. Cox & Chad A. Knoderer. (2015) Linezolid-Associated Thrombocytopenia in Children With Renal Impairment. Journal of the Pediatric Infectious Diseases Society 4:3, pages 272-275.
Crossref
Crossref
Yasuhiro Tsuji, Masato Tashiro, Nobuyuki Ashizawa, Yukio Ota, Hayato Obi, Saori Nagura, Munetoshi Narukawa, Kazuaki Fukahara, Naoki Yoshimura, Hideto To & Yoshihiro Yamamoto. (2015) Treatment of Mediastinitis due to Methicillin-resistant Staphylococcus aureus in a Renal Dysfunction Patient Undergoing Adjustments to the Linezolid Dose. Internal Medicine 54:2, pages 235-239.
Crossref
Crossref
P. Cojutti, N. Maximova, G. Crichiutti, M. Isola & F. Pea. (2014) Pharmacokinetic/pharmacodynamic evaluation of linezolid in hospitalized paediatric patients: a step toward dose optimization by means of therapeutic drug monitoring and Monte Carlo simulation. Journal of Antimicrobial Chemotherapy 70:1, pages 198-206.
Crossref
Crossref
B. Natsumoto, K. Yokota, F. Omata & K. Furukawa. (2014) Risk factors for linezolid-associated thrombocytopenia in adult patients. Infection 42:6, pages 1007-1012.
Crossref
Crossref
H.-Y. Dong, J. Xie, L.-H. Chen, T.-T. Wang, Y.-R. Zhao & Y.-L. Dong. (2014) Therapeutic drug monitoring and receiver operating characteristic curve prediction may reduce the development of linezolid-associated thrombocytopenia in critically ill patients. European Journal of Clinical Microbiology & Infectious Diseases 33:6, pages 1029-1035.
Crossref
Crossref
Takashi Niwa, Tamayo Watanabe, Akio Suzuki, Tomofumi Ohmori, Mayumi Tsuchiya, Tomoyuki Suzuki, Hirotoshi Ohta, Nobuo Murakami & Yoshinori Itoh. (2014) Reduction of linezolid-associated thrombocytopenia by the dose adjustment based on the risk factors such as basal platelet count and body weight. Diagnostic Microbiology and Infectious Disease 79:1, pages 93-97.
Crossref
Crossref
Li-Qing Bi & Su-Ming Zhou. (2014) Thrombocytopenia in Elderly Patients Who Received Intravenous Linezolid Therapy. International Journal of Gerontology 8:1, pages 46-47.
Crossref
Crossref
Kevin J. Downes, Andrea Hahn, Jason Wiles, Joshua D. Courter & Alexander A. Vinks. (2014) Dose optimisation of antibiotics in children: application of pharmacokinetics/pharmacodynamics in paediatrics. International Journal of Antimicrobial Agents 43:3, pages 223-230.
Crossref
Crossref
Zhi-Yong Zhou, Xue-Qin Zhao, Bao-Zhong Shan, Jie Zhu, Xiang Zhang, Qing-Fen Tian, De-Fang Chen & Tang-Hong Jia. (2013) Efficacy and Safety of Linezolid in Treating Gram-Positive Bacterial Infection in the Elderly: A Retrospective Study. Indian Journal of Microbiology 54:1, pages 104-107.
Crossref
Crossref
ZHAORUI ZHANG, ZHIXIN LIANG, HUAIDONG LI, LIANG’AN CHEN & DANYANG SHE. (2014) Comparative evaluation of thrombocytopenia in adult patients receiving linezolid or glycopeptides in a respiratory intensive care unit. Experimental and Therapeutic Medicine 7:2, pages 501-507.
Crossref
Crossref
A. P. Cossu, M. Musu, P. Mura, L. M. De Giudici & G. Finco. (2013) Linezolid-induced thrombocytopenia in impaired renal function: is it time for a dose adjustment? A case report and review of literature. European Journal of Clinical Pharmacology 70:1, pages 23-28.
Crossref
Crossref
Ursula Theuretzbacher. 2014. Fundamentals of Antimicrobial Pharmacokinetics and Pharmacodynamics. Fundamentals of Antimicrobial Pharmacokinetics and Pharmacodynamics
401
443
.
. (2013) In the Literature. Clinical Infectious Diseases 57:11, pages iii-iv.
Crossref
Crossref
Y. Nukui, S. Hatakeyama, K. Okamoto, T. Yamamoto, A. Hisaka, H. Suzuki, N. Yata, H. Yotsuyanagi & K. Moriya. (2013) High plasma linezolid concentration and impaired renal function affect development of linezolid-induced thrombocytopenia. Journal of Antimicrobial Chemotherapy 68:9, pages 2128-2133.
Crossref
Crossref
Donald M. Arnold, Ishac Nazi, Theodore E. Warkentin, James W. Smith, Lisa J. Toltl, James N. George & John G. Kelton. (2013) Approach to the Diagnosis and Management of Drug-Induced Immune Thrombocytopenia. Transfusion Medicine Reviews 27:3, pages 137-145.
Crossref
Crossref
Dario Cattaneo, Giovanna Orlando, Valeria Cozzi, Laura Cordier, Sara Baldelli, Stefania Merli, Serena Fucile, Cecilia Gulisano, Giuliano Rizzardini & Emilio Clementi. (2013) Linezolid plasma concentrations and occurrence of drug-related haematological toxicity in patients with Gram-positive infections. International Journal of Antimicrobial Agents 41:6, pages 586-589.
Crossref
Crossref
D. Breilh. (2013) Optimisation de l’antibiothérapie. Le Pharmacien Hospitalier et Clinicien 48:1, pages 53-63.
Crossref
Crossref
Takashi Niwa. (2013) Establishment of Antimicrobial Stewardship Intervention to Promote the Appropriate Use of Antimicrobial Injection in All Inpatients and Outcomes Evaluation. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) 39:3, pages 125-133.
Crossref
Crossref
Chao Chen, Dai-Hong Guo, Xiutang Cao, Yun Cai, Yuanjie Xu, Man Zhu & Liang Ma. (2012) Risk Factors for Thrombocytopenia in Adult Chinese Patients Receiving Linezolid Therapy. Current Therapeutic Research 73:6, pages 195-206.
Crossref
Crossref
F. Pea, P. Viale, P. Cojutti, B. Del Pin, E. Zamparini & M. Furlanut. (2012) Therapeutic drug monitoring may improve safety outcomes of long-term treatment with linezolid in adult patients. Journal of Antimicrobial Chemotherapy 67:8, pages 2034-2042.
Crossref
Crossref